Quantcast

Latest imidazoles Stories

2014-09-08 12:29:49

WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the generic version of Hospira's Precedex(®) Injection. Par immediately resumed shipping after a U.S. District Court lifted a temporary restraining order that was issued in August at Hospira's request. Last month, Par received final approval from the U.S. Food and Drug Administration...

2014-08-20 23:12:16

New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar Commack, New York (PRWEB) August 20, 2014 Benicar is a widely popular drug prescribed to treat hypertension/high blood pressure. Benicar’s active ingredient is Olmesartan, which in some cases has been shown to injure the blood cells of the small intestine. Olmesartan is also present in Benicar HCT, Tribenzor and Azor. These drugs present the same risk to the small intestine as...

2014-07-19 23:03:05

Benicar Lawsuit News: According to the FDA, Benicar Is Associated With Severe Gastrointestinal Disorder Called Sprue-Like Enteropathy, Which Can Cause Chronic Diarrhea, Rapid Weight Loss, Vomiting, and Other Serious Health Problems. Columbus, OH (PRWEB) July 19, 2014 A Benicar lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with important information regarding a serious gastrointestinal disorder called sprue-like enteropathy that can sometimes accompany...

2014-07-08 23:05:03

Have you experienced intestinal problems after taking Benicar, Azor or Tribenzor? There are current lawsuits being filed on behalf of victims. Toledo, OH (PRWEB) July 08, 2014 The U.S. Food and Drug Administration (FDA) issued a warning on July 3, 2013, that the blood pressure drug, olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause serious intestinal problems known as sprue-like enteropathy. The FDA also required changes to the labels of...

2014-07-02 23:12:29

Kristine Kraft of Schlichter, Bogard & Denton, LLP reports that a French study involving the blood pressure medication Benicar® was recently discussed during the annual Digestive Disease Week (DDW) conference held in Chicago where researchers found Benicar® to be linked to serious gastrointestinal injuries, such as enteropathy. St. Louis, MO (PRWEB) July 02, 2014 A French study involving Benicar® (olmesartan) was recently discussed during the annual Digestive Disease...

2014-07-01 23:12:54

On June 24, the FDA communicated that there is no clear evidence of increased cardiovascular risks associated with use of Olmesartan in diabetic patients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 01, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Olmesartan. The FDA issued...

2014-06-30 23:02:58

The JTB Law Group, LLC has started an informative site called benicarrights.com to educate individuals on their rights for injuries allegedly related to the use of the blood pressure mediation Benicar. Jersey City, NJ (PRWEB) June 30, 2014 The JTB Law Group, LLC has started an informative site called benicarrights.com to educate individuals on their rights for injuries allegedly related to the use of the blood pressure mediation Benicar. The JTB Law Group, LLC, pioneers in mass tort...

2014-06-30 16:26:43

SOUTH SAN FRANCISCO, June 30, 2014 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it has closed a four year, $15 million term loan facility with Oxford Finance LLC. The facility will support the development of CVC for the treatment of nonalcoholic steatohepatitis (NASH) and for working capital and general corporate needs. About Tobira Therapeutics Tobira Therapeutics is...

2014-06-27 23:07:56

Kristine Kraft of Schlichter, Bogard & Denton, LLP reports that a recent lawsuit alleges that the blood pressure medication Benicar® is linked to serious gastrointestinal injuries, such as enteropathy. St. Louis, MO (PRWEB) June 27, 2014 A new lawsuit has been filed in the Superior Court of New Jersey (Case No. ATL-L-506-14) against the drug manufacturer Daiichi Sankyo alleging severe gastrointestinal injuries as a result of ingesting the drug Benicar® (olmesartan...

2014-05-23 16:24:17

OTTAWA, May 23, 2014 /CNW/ - The issue: Pharmascience Inc., in consultation with Health Canada, is recalling one lot of PMS-Losartan-HCTZ due to a labelling error on the blister pack (see photo below). The printed boxes of the product show the proper dosage "Losartan-HCTZ100/25mg," while some blisters or inner packages incorrectly say "Losartan-HCTZ 100/12.5mg." The product is packaged with 100/25mg tablets. Taking more of the drug than prescribed could have serious health...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'